HOME    SEARCH    ABOUT US    CONTACT US    HELP   
           
Rule: 37.114.313 Prev     Up     Next    
Rule Title: CONFIRMATION OF DISEASE
Add to My Favorites
Add to Favorites
Department: PUBLIC HEALTH AND HUMAN SERVICES
Chapter: COMMUNICABLE DISEASE CONTROL
Subchapter: General Control Measures
 
Latest version of the adopted rule presented in Administrative Rules of Montana (ARM):

Printer Friendly Version

37.114.313    CONFIRMATION OF DISEASE

(1) Subject to the limitation in (2), if a local health officer receives information about a case of any of the following diseases, the officer must work with the department to ensure that a specimen from the case is submitted to the department, when possible, which will be analyzed to confirm the existence or absence of the disease in question, or for further examination associated with surveillance or investigation of disease transmission:

(a) Anthrax;

(b) Arboviral diseases, neuroinvasive and non-neuroinvasive (California serogroup, Chikungunya, Eastern equine encephalitis, Powassan, Saint Louis encephalitis, West Nile virus, Western equine encephalitis, Zika virus infection);

(c) Botulism;

(d) Brucellosis;

(e) Candida auris (C. auris);

(f) Carbapenem-Resistant Organisms;

(g) Cholera;

(h) Diphtheria;

(i) Escherichia coli, Shiga toxin-producing (STEC);

(j) Haemophilus influenzae invasive disease;

(k) Hantavirus pulmonary syndrome or infection;

(l) Influenza;

(m) Listeriosis;

(n) Measles (rubeola);

(o) Meningococcal disease (Neisseria meningitidis);

(p) Plague;

(q) Poliomyelitis, paralytic or non-paralytic;

(r) Rabies (human);

(s) Rubella (including congenital);

(t) Salmonellosis (including Salmonella Typhi and Paratyphi);

(u) Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) disease;

(v) Shigellosis;

(w) Smallpox;

(x) Trichinellosis (Trichinosis);

(y) Tuberculosis disease;

(z) Tularemia;

(aa) Vancomycin-intermediate staphylococcus aureus (VISA);

(ab) Vancomycin-resistant staphylococcus aureus (VRSA); and

(ac) Vibriosis.

(2) In the event of an outbreak, emergence of a communicable disease or a disease of public health importance, specimens must be submitted at the request of the department until a representative sample has been reached as determined by the department. 

(3) A laboratory professional or any other person in possession of a specimen from a case of a disease listed in (1) must submit the specimen to the department upon request.

(4) If no specimen from the case is otherwise available and the case refuses to allow a specimen to be taken for purposes of (1), the case will be assumed to be infected and must comply with whatever control measures are imposed by the department, or the local health officer.

 

History: 50-1-202, 50-1-204, MCA; IMP, 50-1-202, 50-1-204, MCA; NEW, 1987 MAR p. 2147, Eff. 11/28/87; AMD, 1994 MAR p. 1295, Eff. 5/13/94; AMD, 1995 MAR p. 1127, Eff. 6/30/95; AMD, 2000 MAR p. 2528, Eff. 9/22/00; TRANS, from DHES, 2002 MAR p. 913; AMD, 2006 MAR p. 2112, Eff. 9/8/06; AMD, 2013 MAR p. 967, Eff. 6/7/13; AMD, 2017 MAR p. 343, Eff. 3/25/17; AMD, 2019 MAR p. 1745, Eff. 1/1/20.


 

 
MAR Notices Effective From Effective To History Notes
37-887 1/1/2020 Current History: 50-1-202, 50-1-204, MCA; IMP, 50-1-202, 50-1-204, MCA; NEW, 1987 MAR p. 2147, Eff. 11/28/87; AMD, 1994 MAR p. 1295, Eff. 5/13/94; AMD, 1995 MAR p. 1127, Eff. 6/30/95; AMD, 2000 MAR p. 2528, Eff. 9/22/00; TRANS, from DHES, 2002 MAR p. 913; AMD, 2006 MAR p. 2112, Eff. 9/8/06; AMD, 2013 MAR p. 967, Eff. 6/7/13; AMD, 2017 MAR p. 343, Eff. 3/25/17; AMD, 2019 MAR p. 1745, Eff. 1/1/20.
37-775 3/25/2017 1/1/2020 History: 50-1-202, 50-1-204, MCA; IMP, 50-1-202, 50-1-204, MCA; NEW, 1987 MAR p. 2147, Eff. 11/28/87; AMD, 1994 MAR p. 1295, Eff. 5/13/94; AMD, 1995 MAR p. 1127, Eff. 6/30/95; AMD, 2000 MAR p. 2528, Eff. 9/22/00; TRANS, from DHES, 2002 MAR p. 913; AMD, 2006 MAR p. 2112, Eff. 9/8/06; AMD, 2013 MAR p. 967, Eff. 6/7/13; AMD, 2017 MAR p. 343, Eff. 3/25/17.
37-624 6/7/2013 3/25/2017 History: 50-1-202, 50-1-204, MCA; IMP, 50-1-202, 50-1-204, MCA; NEW, 1987 MAR p. 2147, Eff. 11/28/87; AMD, 1994 MAR p. 1295, Eff. 5/13/94; AMD, 1995 MAR p. 1127, Eff. 6/30/95; AMD, 2000 MAR p. 2528, Eff. 9/22/00; TRANS, from DHES, 2002 MAR p. 913; AMD, 2006 MAR p. 2112, Eff. 9/8/06; AMD, 2013 MAR p. 967, Eff. 6/7/13.
9/8/2006 6/7/2013 History: 50-1-202, 50-1-204, MCA; IMP, 50-1-202, 50-1-204, MCA; NEW, 1987 MAR p. 2147, Eff. 11/28/87; AMD, 1994 MAR p. 1295, Eff. 5/13/94; AMD, 1995 MAR p. 1127, Eff. 6/30/95; AMD, 2000 MAR p. 2528, Eff. 9/22/00; TRANS, from DHES, 2002 MAR p. 913; AMD, 2006 MAR p. 2112, Eff. 9/8/06.
Home  |   Search  |   About Us  |   Contact Us  |   Help  |   Disclaimer  |   Privacy & Security